TABLE 3.
Oligonucleotide primers used in this study
Name | Sequence in 5′ to 3′ directiona |
---|---|
5′GFP-XhoI | AGCTctcgagATGAGTAAGGGAGAAGAACTTTTCACTGGA |
3'GFP-EcoRV | AGCTgatatcTTATTTGTATAGTTCATCCATGCCATGTGT |
5′CaACT1term-EcoRI | AGCTgaattcGAGTGAAATTCTGGAAATCTGGAAATCT |
3'CaACT1term-SpeI | AGCTactagtTAGATTATGGTCGACATTTTATGATGGAAT |
5′NEUfwd-ApaI | ACTGgggcccGTAATTGTAGTAAGAATGACAAGTATCAG |
5'NEUrev-ANP-XhoI | ACTGctcgagttaattaaggcgccggcgcgccGGAAGGACGATGAAGGAGAGAAAG |
3′NEUfwd-SacII | ACTGccgcggTAAACAAGTGGTATTCAAGCACAATTC |
3'NEUT5L-SacIPacI | GCTGgagctcttaattaaTAACCCACTGAATTCTACATCGAAC |
3'ECE1prom-XhoI | TCATctcgagTTTAACGAATGGAAAATAGTTGGTAGTAAAATAAAGG |
5′ECE1prom500-AscI | TTCCggcgcgccGTCATTTGTAGGATTTTCAGCAGAACA |
5′ECE1prom1000-AscI | TTCCggcgcgccAGCGAAACATTTTTTTTTTTCAACGGCTC |
5′ECE1prom1500-AscI | TTCCggcgcgccACCCTAGTAATTATATGAAACATGCCCA |
5′ECE1prom2000-AscI | TTCCggcgcgccAACATTAACGACGCAAAATACAAACTTGGT |
5′ECE1prom2500-AscI | TTCCggcgcgccGTAAGCATTTTGGAGTAATACCATAGTTG |
5′ECE1prom3000-AscI | TTCCggcgcgccGCAAATAGAATTGTTCTATTGCTTAGCTTTAG |
R1-CaACT1 | TCAGACCAGCTGATTTAGGTTTG |
R2-CaACT1 | GTGAACAATGGATGGACCAG |
R1-CaECE1 | ATCGAAAATGCCAAGAGAG |
R2-CaECE1 | AGCATTTTCAATACCGACAG |
R1-CaGFP | CTGAAGTCAAGTTTGAAGGTGATAC |
R2-CaGFP | GCAGATTGTGTGGACAAGTAATG |
GFP veri rev | TGATCTGGGTATCTCGCAAAGCAT |
Lowercase: restriction sites.